This is a preprint.
Estimating the sensitivity of non-treponemal and treponemal antibody tests in primary syphilis
- PMID: 41282729
- PMCID: PMC12637747
- DOI: 10.1101/2025.11.07.25339586
Estimating the sensitivity of non-treponemal and treponemal antibody tests in primary syphilis
Abstract
Among patients with primary syphilis, sensitivity of TRUST was 55% (6/11) compared to darkfield microscopy (DFM) and 60% (9/15) compared to Treponema pallidum PCR. Sensitivity of RPR was 78% (38/49) and 93% (43/46), respectively. TPPA had a sensitivity of 95% (41/43) compared to DFM and 96% (43/45) compared to PCR.
Keywords: Syphilis; diagnostics; non-treponemal testing.
Conflict of interest statement
ACS reports royalties from UptoDate; past honoraria from Innoviva Specialty Therapeutics and Hologic, Inc, for their scientific advisory board and conference travel, respectively; and support for meetings or travel from the American Sexually Transmitted Diseases Association as a member of the Executive Board outside the scope of the current work. JAG-L reports honoraria from the Universidad de Antioquia; support for meetings or travel from Carnott Laboratories, Cantabria Labs, Epidermique, Pharmaderm, and Janssen; receipt of writing materials from Epidermique, Cantabria labs, Isdin, Pharmaderm, Skindrugs, Loreal, Galderma, Cetaphil, Cerave, Isispharma, Carnott, Janssen, Pharmalab, Novartis, Pfizer, and Lilly outside of the scope of work. JDR receives royalties from Biokit, Chembio, and Span Diagnostics for syphilis serodiagnostic reagents. JBP reports non-financial support from Abbott Diagnostics and past research support from Gilead Sciences, all outside the scope of the current work. This project was funded in part by the National Institute for Allergy and Infectious Diseases (NIAID; U19AI144177 to JDR and MAM). This work also was supported, in part, by the Bill & Melinda Gates Foundation (INV-036560 to ACS) and strategic research dollars from Connecticut Children’s. SFS is supported by NIH NIAID grant #T32-AI007001.
References
-
- Theel ES, Katz SS, Pillay A. Molecular and direct detection tests for Treponema pallidum subspecies pallidum: a review of the literature, 1964–2017. Clin Infect Dis Off Publ Infect Dis Soc Am. 2020;71(Suppl 1):S4–S12. doi: 10.1093/cid/ciaa176 - DOI
-
- Flipse J, Niekamp AM, Dirks A, et al. Refining timely diagnosis of early syphilis by using Treponema pallidum PCR or IgM immunoblotting next to conventional serology for syphilis. J Clin Microbiol. 61(6):e00112–23. doi: 10.1128/jcm.00112-23 - DOI
-
- Papp JR, Park IU, Fakile Y, Pereira L, Pillay A, Bolan GA. CDC laboratory recommendations for syphilis testing, United States, 2024. MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep. 2024;73(1):1–32. doi: 10.15585/mmwr.rr7301a1 - DOI
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources